Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention

Introduction: There is some controversy over the efficacy of statins for the prevention of contrastinduced nephropathy (CIN). There have also been reports on varying efficacies of different statins. Hence, in this study the efficacy of atorvastatin and rosuvastatin for the prevention of CIN was asse...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Cardiovasc Thorac Res
Glavni autori: Firouzi, Ata, Kazem Moussavi, Ali, Mohebbi, Ahmad, Alemzadeh-Ansari, Mohammad Javad, Kiani, Reza, Sanati, Hamid Reza, Mohebbi, Bahram, Shakerian, Farshad, Zahedmehr, Ali, Ansari-Ramandi, Mohammad Mostafa, Oni Heris, Saeed, Ghaleshi, Bahar, Ghorbani, Fatemeh
Format: Artigo
Jezik:Inglês
Izdano: Tabriz University of Medical Sciences 2018
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6203872/
https://ncbi.nlm.nih.gov/pubmed/30386535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/jcvtr.2018.24
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items